20
Participants
Start Date
April 30, 2016
Primary Completion Date
January 21, 2019
Study Completion Date
January 21, 2019
JKB-122
Orally administered capsules of JKB-122 which will be taken once daily with dose escalation from 5mg up to 40mg depending on the monthly response.
Mount Sinai Hospital, New York
Duke University Medical Center, Durham
Indiana University School of Medicine, Indianapolis
Northwestern University, Chicago
Methodist Dallas Medical Center, Dallas
Advanced Liver Therapies, Baylor College of Medicine, Houston
The Texas Liver Institute, San Antonio
Ruane Clinical Research Group, Inc., Los Angeles
University of California Davis Medical Center - Ticon 1, Sacramento
Swedish Medical Center - Organ Transplant and Liver Center, Seattle
University of Washington, Seattle
California Pacific Medical Center, San Francisco
Tulane University, New Orleans
Massachusetts General Hospital, Boston
Taxes Liver Institute, San Antonio
University of Florida Hepatology Research at CTRB, Gainesville
TaiwanJ Pharmaceuticals Co., Ltd
INDUSTRY